All About Antibody Drug Conjugations (ADCs) | LIVE Office Hours Discussion

In this video, you'll see a discussion from our LIVE Office Hours call with cancer specialist Alex Rolland and advocacy expert Michelle Morand. Alex explains why a new type of cancer treatment - called Antibody Drug Conjugates - are a game-changer for many patients and how to find out if they'll work for you.
These live Zoom calls happen each Wednesday as a part of our free Cancer Care Advocacy & Education Support Group, called Cancer Just the Facts.
👉 Join Cancer Just the Facts (free) and get access to a variety of resources on Precision Cancer Medicine as well as access to our weekly Zoom calls: cancerjustthefacts.com/
Book a Free Session With Alex And His Precision Oncology Team: www.ctoam.com/free-strategy-s...
Download CTOAM’S Free Ebook Here: www.ctoam.com/ebook/
-
CTOAM is a worldwide, Canadian-based personalized cancer care and precision oncology service specializing in getting our client's rapid access to the best possible cancer treatment available for their form of cancer, while assisting their physicians in having the most current data from which to make confident treatment decisions on your behalf.
We facilitate access to peer-reviewed, science-based precision diagnostics such as PET/CT scans, liquid biopsy (blood-based genetic tests) and detailed genetic panels. We use these leading diagnostic tools, combined with a thorough and personalized research review, as our team explores the most advanced scientific data available today to find the best options for you.
Other ways to stay in touch with CTOAM:
Facebook: / cancertreatmentoptions...
LinkedIn: / ctoam
Twitter: / ctoam
Blog: research.ctoam.com/
LinkedIn (Liquid Biopsy Labs): / 13063544
LBL Twitter: / liquidbiopsynow
Disclaimer:
Please understand that these videos are meant for educational purposes only. These videos are not intended to diagnose or be used as treatment advice. Viewers are encouraged to speak with their doctor or healthcare professionals for medical advice and before making any changes to their healthcare based on this information. All statements made in this video regarding medical treatments and health conditions are sourced and have been approved by the U.S. Food and Drug Administration (FDA). Watching this video is not a substitute for professional medical advice or a diagnosis.

[@clintcarter]

Sounds like the future is here.

[@wanazuzo]

Theoretically, can a single patient target more than one receptor?

[@justcancerfacts]

Hello! so sorry for the great delay! did not see this here. yes, we can target multiple mutations/receptors at once - most patients have numerous mutations that are involved in their cancer and for most a combination of 3 or 4 treatments is required in order to target the primary/driving mutations. the key is to have thorough tumour DNA (550+ genes) and RNA (20,813 genes) testing so that all the targets are identified and you know which are most prevalent (ie. some mutations are only present in a small percentage of your cells and you don't want to target those - at least not at this time - and others are present in a high percentage (driving mutations) - those are the ones you want to target - DNA testing tells you which cancer related mutations you have and RNA expression testing is how you tell which of those are most prevalent. hope that helps.